Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Denton

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
ACS Medicinal Chemistry Letters|February 20, 2018
Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK InhibitorsMatthew F Sammons, Sujay V Kharade, Kevin J Filipski, et al.
Iscience|October 20, 2025
K<sub>ir</sub>5.1-modulated potassium flux stimulates an anabolic kidney phenotypeAihua Wu, Masa-Ki Inoue, Yahua Zhang, et al.
Molecular Pharmacology|March 5, 2022
VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium ChannelsSamantha J McClenahan, Caitlin N Kent, Sujay V Kharade, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Highly Potent and Subtype-Selective Sperm-Specific Potassium Channel SLO3 Inhibitors Display High Tissue Exposure in the Murine Female Reproductive TractKayla J Temple, Ping Li, Hallie G McKinnie, et al.
Journal of Medicinal Chemistry|October 17, 2025
Optimization of Selective and CNS Penetrant Alkyne-Based TREK Inhibitors: The Discovery and Characterization of ONO-9517601 (VU6022856) and ONO-7927846 (VU6024391)Motoyuki Tanaka, Yoko Sekioka, Gakuji Hashimoto, et al.
EMBO Molecular Medicine|July 25, 2014
The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancyConor McCloskey, Cara Rada, Elizabeth Bailey, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
ACS Medicinal Chemistry Letters|February 20, 2018
Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK InhibitorsMatthew F Sammons, Sujay V Kharade, Kevin J Filipski, et al.
Iscience|October 20, 2025
K<sub>ir</sub>5.1-modulated potassium flux stimulates an anabolic kidney phenotypeAihua Wu, Masa-Ki Inoue, Yahua Zhang, et al.
Molecular Pharmacology|March 5, 2022
VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium ChannelsSamantha J McClenahan, Caitlin N Kent, Sujay V Kharade, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Highly Potent and Subtype-Selective Sperm-Specific Potassium Channel SLO3 Inhibitors Display High Tissue Exposure in the Murine Female Reproductive TractKayla J Temple, Ping Li, Hallie G McKinnie, et al.
Journal of Medicinal Chemistry|October 17, 2025
Optimization of Selective and CNS Penetrant Alkyne-Based TREK Inhibitors: The Discovery and Characterization of ONO-9517601 (VU6022856) and ONO-7927846 (VU6024391)Motoyuki Tanaka, Yoko Sekioka, Gakuji Hashimoto, et al.
EMBO Molecular Medicine|July 25, 2014
The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancyConor McCloskey, Cara Rada, Elizabeth Bailey, et al.
Pageof 15